These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24253258)

  • 21. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
    J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity in
    Phillips KN; Widmann S; Lai HY; Nguyen J; Ray JCJ; Balázsi G; Cooper TF
    mBio; 2019 Nov; 10(6):. PubMed ID: 31719176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effector Overlap between the
    Narang A; Oehler S
    J Bacteriol; 2017 May; 199(9):. PubMed ID: 28193904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.
    McCaskill J; Singhania R; Burgess M; Allavena R; Wu S; Blumenthal A; McMillan NA
    Mol Ther Nucleic Acids; 2013 Jun; 2(6):e96. PubMed ID: 23736774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels.
    Hassani Z; Lemkine GF; Erbacher P; Palmier K; Alfama G; Giovannangeli C; Behr JP; Demeneix BA
    J Gene Med; 2005 Feb; 7(2):198-207. PubMed ID: 15515135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA polymerase II transcription blocked by Escherichia coli lac repressor.
    Deuschle U; Hipskind RA; Bujard H
    Science; 1990 Apr; 248(4954):480-3. PubMed ID: 2158670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.
    Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A
    J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of gene expression in tobacco cells using a bacterial operator-repressor system.
    Wilde RJ; Shufflebottom D; Cooke S; Jasinska I; Merryweather A; Beri R; Brammar WJ; Bevan M; Schuch W
    EMBO J; 1992 Apr; 11(4):1251-9. PubMed ID: 1563343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the Escherichia coli lac repressor and operator to control gene expression in Bacillus subtilis.
    Yansura DG; Henner DJ
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):439-43. PubMed ID: 6420789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of isopropyl-beta-D-thiogalactopyranosid induction of the lac operon on the specificity of spontaneous and doxorubicin-induced mutations in Escherichia coli.
    Veigl ML; Donover SP; Anderson RD; Akst L; Sedwick CE; Sedwick WD
    Environ Mol Mutagen; 1995; 26(1):16-25. PubMed ID: 7641704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements.
    Liu HS; Scrable H; Villaret DB; Lieberman MA; Stambrook PJ
    Cancer Res; 1992 Feb; 52(4):983-9. PubMed ID: 1737361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducible gene expression from vaccinia virus vectors.
    Rodriguez JF; Smith GL
    Virology; 1990 Jul; 177(1):239-50. PubMed ID: 2191497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model.
    Gonzalez-Gonzalez E; Ra H; Hickerson RP; Wang Q; Piyawattanametha W; Mandella MJ; Kino GS; Leake D; Avilion AA; Solgaard O; Doyle TC; Contag CH; Kaspar RL
    Gene Ther; 2009 Aug; 16(8):963-72. PubMed ID: 19474811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of hha and ler in transcriptional regulation of the esp operon of enterohemorrhagic Escherichia coli O157:H7.
    Sharma VK; Zuerner RL
    J Bacteriol; 2004 Nov; 186(21):7290-301. PubMed ID: 15489441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the tetracycline system for inducible protein synthesis in the kidney.
    Gallagher AR; Schönig K; Brown N; Bujard H; Witzgall R
    J Am Soc Nephrol; 2003 Aug; 14(8):2042-51. PubMed ID: 12874458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept.
    Chong RH; Gonzalez-Gonzalez E; Lara MF; Speaker TJ; Contag CH; Kaspar RL; Coulman SA; Hargest R; Birchall JC
    J Control Release; 2013 Mar; 166(3):211-9. PubMed ID: 23313112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of inducers of the E.coli lac repressor system in mammalian cells and whole animals.
    Wyborski DL; Short JM
    Nucleic Acids Res; 1991 Sep; 19(17):4647-53. PubMed ID: 1891356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vector-based in vivo RNA interference: dose- and time-dependent suppression of transgene expression.
    Kobayashi N; Matsui Y; Kawase A; Hirata K; Miyagishi M; Taira K; Nishikawa M; Takakura Y
    J Pharmacol Exp Ther; 2004 Feb; 308(2):688-93. PubMed ID: 14610223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of polymeric nanoparticles for siRNA delivery to down-regulate the expressions of exogenous and endogenous target genes.
    Huang W; Lv M; Gao ZG; Jin MJ; Xu YJ; Yu XD; Jin ZH; Yin XZ
    Pharmazie; 2012 Aug; 67(8):676-80. PubMed ID: 22957431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current issues of RNAi therapeutics delivery and development.
    Haussecker D
    J Control Release; 2014 Dec; 195():49-54. PubMed ID: 25111131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.